1. Home
  2. SMID vs CGEN Comparison

SMID vs CGEN Comparison

Compare SMID & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMID
  • CGEN
  • Stock Information
  • Founded
  • SMID 1960
  • CGEN 1993
  • Country
  • SMID United States
  • CGEN Israel
  • Employees
  • SMID N/A
  • CGEN N/A
  • Industry
  • SMID Building Materials
  • CGEN Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SMID Industrials
  • CGEN Health Care
  • Exchange
  • SMID Nasdaq
  • CGEN Nasdaq
  • Market Cap
  • SMID 157.4M
  • CGEN 167.4M
  • IPO Year
  • SMID 1995
  • CGEN 2000
  • Fundamental
  • Price
  • SMID $36.79
  • CGEN $1.54
  • Analyst Decision
  • SMID
  • CGEN
  • Analyst Count
  • SMID 0
  • CGEN 0
  • Target Price
  • SMID N/A
  • CGEN N/A
  • AVG Volume (30 Days)
  • SMID 21.3K
  • CGEN 204.3K
  • Earning Date
  • SMID 07-10-2025
  • CGEN 08-05-2025
  • Dividend Yield
  • SMID N/A
  • CGEN N/A
  • EPS Growth
  • SMID 444.88
  • CGEN N/A
  • EPS
  • SMID 1.86
  • CGEN N/A
  • Revenue
  • SMID $84,450,000.00
  • CGEN $27,589,000.00
  • Revenue This Year
  • SMID N/A
  • CGEN N/A
  • Revenue Next Year
  • SMID N/A
  • CGEN $105.77
  • P/E Ratio
  • SMID $20.71
  • CGEN N/A
  • Revenue Growth
  • SMID 33.01
  • CGEN N/A
  • 52 Week Low
  • SMID $25.13
  • CGEN $1.13
  • 52 Week High
  • SMID $51.96
  • CGEN $2.66
  • Technical
  • Relative Strength Index (RSI)
  • SMID 69.87
  • CGEN 45.94
  • Support Level
  • SMID $35.07
  • CGEN $1.46
  • Resistance Level
  • SMID $39.02
  • CGEN $1.74
  • Average True Range (ATR)
  • SMID 1.72
  • CGEN 0.09
  • MACD
  • SMID 0.42
  • CGEN -0.02
  • Stochastic Oscillator
  • SMID 83.71
  • CGEN 38.89

About SMID Smith-Midland Corporation

Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Share on Social Networks: